Vanguard Capital Management
KRSA

Vanguard Capital Management’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Vanguard Capital Management’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$105K Buy
4,416
+2,111
+92% +$6.85K ﹤0.01% 3872
2026
Q1 		$24.8K Buy
+2,305
New +$3.28K ﹤0.01% 3968

Other funds holding KRSA

KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management's KRSA Position: Q2 2026 in Review

Vanguard Capital Management increased its Korsana Biosciences, Inc. Common Stock (KRSA) stake by 92% in Q2 2026, buying an estimated $6.85K and bringing the position to 4,416 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #3872.

Vanguard Capital Management first reported a position in KRSA in Q1 2026 and has held it in 2 quarters since. 21 funds tracked by Wall St. Rank hold KRSA as of Q2 2026.

  • Vanguard Capital Management held 4,416 shares of Korsana Biosciences, Inc. Common Stock worth $105K as of Q2 2026.
  • Vanguard Capital Management bought 2,111 Korsana Biosciences, Inc. Common Stock shares in Q2 2026, an estimated $6.85K.
  • Korsana Biosciences, Inc. Common Stock made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3872 holding.
  • Vanguard Capital Management first reported a position in Korsana Biosciences, Inc. Common Stock in Q1 2026 and has held it in 2 quarters since.
  • 21 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.